Regulation of p53 stability as a therapeutic strategy for cancer

Zhifei Xu1, Wentong Wu1, Hao Yan1

  • 1Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Biochemical Pharmacology
|January 9, 2021
PubMed

Insights

This review explores how compounds degrade the tumor suppressor protein p53, crucial for cell death and homeostasis. Understanding p53 stability regulation offers new therapeutic strategies for cancer and other diseases.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • The tumor suppressor protein p53 regulates vital biological functions including cell death, metabolic homeostasis, and immune responses.
  • Mutations in the p53 gene occur in about 50% of human cancers, leading to oncogenic functions that promote tumor progression and chemoresistance.
  • Precise regulation of both wild-type and mutant p53 stability is essential for normal cellular functions and represents a key therapeutic target in cancer treatment.

Purpose of the Study:

  • To review compound-induced degradation of p53 through proteasome and autophagy-lysosome pathways.
  • To discuss other post-translational modifications influencing p53 stability and biological functions.
  • To provide a theoretical basis for p53 abundance regulation and its therapeutic applications in various diseases.

Main Methods:

  • Literature review focusing on compound-induced p53 degradation mechanisms.
  • Analysis of ubiquitination-dependent proteasome and autophagy-lysosome pathways in p53 regulation.
  • Examination of various post-translational modifications affecting p53 stability.

Main Results:

  • Compounds can induce p53 degradation via both the ubiquitination-dependent proteasome and autophagy-lysosome pathways.
  • Post-translational modifications significantly control p53 stability and its associated biological functions.
  • Targeting p53 stability through compound-induced degradation is a promising therapeutic strategy.

Conclusions:

  • The regulation of p53 stability is critical for maintaining normal cellular functions and preventing diseases like cancer.
  • Understanding the mechanisms of p53 degradation offers potential therapeutic avenues for cancer and other p53-related disorders.
  • This review consolidates current knowledge on p53 stability regulation, highlighting its implications for disease treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K